Cuenca, Analyn A.

HRN: 27-32-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2025
CEFTRIAXONE 1G (VIAL)
06/16/2025
06/23/2025
IV
2grams
Once Daily
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: